Nutrition
Volume 19, Issue 7 , Pages 686-692, July 2003

Folic acid says NO to vascular diseases

  • Undurti N Das, MD, FAMS

      Affiliations

    • EFA Sciences LLC, Norwood, Massachusetts, USA
    • Corresponding Author InformationCorrespondence to: Undurti N. Das, MD, FAMS, EFA Sciences LLC, 1420 Providence Highway, Suite 266, Norwood, MA 02062, USA.

Abstract 

Objectives

The possible link between folic acid or folate and tetrahydrobiopterin (H4B), vitamin C, polyunsaturated fatty acids (PUFAs), and nitric oxide (NO), which may explain the beneficial actions of these nutrients in various vascular conditions, was investigated.

Methods

The literature pertaining to the actions of folic acid/folate, H4B, vitamin C, PUFAs, and NO was reviewed.

Results

Impaired endothelial NO (eNO) activity is an early marker for cardiovascular disease. Most risk factors for atherosclerosis are associated with impaired endothelium-dependent vasodilatation due to reduced NO production. Folate not only reduces plasma homocysteine levels but also enhances eNO synthesis and shows anti-inflammatory actions. It stimulates endogenous H4B regeneration, a cofactor necessary for eNO synthesis, inhibits intracellular superoxide generation, and thus enhances the half-life of NO. H4B in turn enhances NO generation and augments arginine transport into the cells. Folic acid increases the concentration of ω-3 PUFAs, which also enhance eNO synthesis. Vitamin C augments eNO synthesis by increasing intracellular H4B and stabilization of H4B. Insulin stimulates H4B synthesis and PUFA metabolism, suppresses the production of proinflammatory cytokine tumor necrosis factor-α and superoxide anion, and enhances NO generation. The ability of folate to augment eNO generation is independent of its capacity to lower plasma homocysteine levels.

Conclusions

The common mechanism by which folic acid, H4B, vitamin C, ω-3 fatty acids, and l-arginine bring about their beneficial actions in various vascular diseases is by enhancing eNO production. Hence, it remains to be determined whether a judicious combination of folic acid, vitamins B12, B6, and C, H4B, l-arginine, and ω-3 fatty acids in appropriate amounts may form a novel approach in the prevention and management of various conditions such as hyperlipidemias, coronary heart disease, atherosclerosis, peripheral vascular disease, and some neurodegenerative conditions.

Keywords:  homocysteine, coronary heart disease, folic acid, vitamin C, polyunsaturated fatty acids, nitric oxide, l-arginine, tetrahydrobiopterin, superoxide anion, lipid peroxidation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0899-9007(02)01044-4

doi:10.1016/S0899-9007(02)01044-4

Nutrition
Volume 19, Issue 7 , Pages 686-692, July 2003